Science Explorer Back to mapMap
Discussion
Researcher · Nanjing University · China

Zikuan Gu

Zikuan Gu publishes mostly in Biomedical Engineering, Immunology and Molecular Biology, on topics such as Nanoplatforms for cancer theranostics, Analytical chemistry methods development and Nanoparticle-Based Drug Delivery.

ORCID 0009-0003-4582-0600 OpenAlex
World rank
#2,083,208
of 7,710,434 ranked researchers
Rank in China
#321,606
of 978,568
Works
19
Citations
579
Citations per work
30.5
h-index
11
i10-index 11Top 56% in Biomedical Engineering
Zikuan Gu

What does Zikuan Gu research?

Zikuan Gu's work is mostly in Immunology and Microbiology (16%), Engineering (16%), Biochemistry, Genetics and Molecular Biology (11%).

Physical Sciences: 6 works · 33.9% of their workEngineering: 3 works · 16.1% of their workBiomedical Engineering: 3 works · 16.1% of their workChemistry: 2 works · 10.7% of their workAnalytical Chemistry: 2 works · 10.7% of their workMaterials Science: 1 works · 7.1% of their workBiomaterials: 1 works · 7.1% of their workEverything else: 6 works · 32.2% of their workLife Sciences: 5 works · 26.8% of their workImmunology and Microbiology: 3 works · 16.1% of their workImmunology: 3 works · 16.1% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 10.7% of their workMolecular Biology: 2 works · 10.7% of their workHealth Sciences: 1 works · 7.1% of their workMedicine: 1 works · 7.1% of their workOncology: 1 works · 7.1% of their workTHEIR WORKZikuan Gu19works
Life Sciences27%Physical Sciences34%Health Sciences7%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Engineering316.1%
    2. Chemistry210.7%
    3. Materials Science17.1%
  2. Everything else632.2%
    1. Immunology and Microbiology316.1%
    2. Biochemistry, Genetics and Molecular Biology210.7%
    1. Medicine17.1%
  1. 1Biomedical Engineering16% of their works
  2. 2Immunology16% of their works
  3. 3Molecular Biology11% of their works
  4. 4Analytical Chemistry11% of their works
  5. 5Biomaterials7% of their works
  6. 6Oncology7% of their works

Research topics

Which keywords describe Zikuan Gu's research?

The keywords of their largest research topics: Nanoparticles, Tumor Targeting, Photothermal Therapy, Reactive Oxygen Species, Molecularly Imprinted Polymers, Solid-Phase Microextraction, Drug Delivery and Nanocarriers.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Nanoparticles143 topics
  2. Tumor Targeting112 topics
  3. Photothermal Therapy71 topic
  4. Reactive Oxygen Species71 topic
  5. Molecularly Imprinted Polymers61 topic
  6. Solid-Phase Microextraction61 topic
  7. Drug Delivery41 topic
  8. Nanocarriers41 topic
  9. DNA nanotechnology31 topic
  10. Fc Receptors31 topic
  11. NK Cell Recognition31 topic
  12. Natural Killer Cells31 topic
  13. Self-Assembly31 topic
  14. Therapeutic Antibodies31 topic
  15. Dendritic Cells21 topic
  16. HIF-121 topic
  17. Immunity21 topic
  18. Warburg Effect21 topic

Where does Zikuan Gu work?

Zikuan Gu's main affiliation in the publication record is Nanjing University, China.

How many publications and citations does Zikuan Gu have?

OpenAlex counts 19 works and 579 citations for Zikuan Gu, an h-index of 11, ranking #2,083,208 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Zikuan Gu. Posts are plain text and can be reported.